Dr. Tait is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1350 S Kings Dr
Charlotte, NC 28207Phone+1 704-446-1544Fax+1 704-355-5073
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Gynecologic Oncology, 1994
- University of TennesseeResidency, Obstetrics and Gynecology, 1987 - 1991
- University of Tennessee Health Science Center College of MedicineClass of 1987
Certifications & Licensure
- NC State Medical License 1998 - 2025
- TN State Medical License 1988 - 2003
- TX State Medical License 1991 - 1994
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 4 citationsImproved Rates of Same-day Discharge in Patients Undergoing Surgery for Endometrial Cancer Following the COVID-19 Pandemic.Brittany F Lees, Shelby Johnson, Erin Donahue, Rupali Bose, Jubilee Brown
Journal of Minimally Invasive Gynecology. 2022-11-01 - 5 citationsEnhanced recovery after surgery (ERAS) protocol is associated with lower post-operative opioid use and a reduced office burden after minimally invasive surgery.Khrystyna Levytska, Ziqing Yu, Meghan Wally, Susan Odum, Joseph R Hsu
Gynecologic Oncology. 2022-09-01 - 3 citationsamplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer.Wendell Jones, David Tait, Chad Livasy, Mahrukh Ganapathi, Ram Ganapathi
NAR Cancer. 2022-09-01
Journal Articles
- Case Report Clonal Lineage of High Grade Serous Ovarian Cancer in a Patient with Neurofibromatosis Type 1David L Tait, Jeffrey S Kneisl, Chad A Livasy, ScienceDirect
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: